Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05805306 · ClinicalTrials.gov registry record · NA

Entre Herman@s: Promoting Health Among Latino MSM

A NA study of HIV Infections, sponsored by Charles Drew University of Medicine and Science.

Active
Registry status
NA
Development phase
288
Enrollment target
1
Study location

NCT05805306 is a NA study of HIV Infections that is active but no longer recruiting, run by Charles Drew University of Medicine and Science. The registered enrollment target is 288 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05805306, a NA study of HIV Infections, is active but no longer recruiting, sponsored by Charles Drew University of Medicine and Science.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
288 participants
Enrollment target
1
Study location

Study Summary

This is a randomized controlled trial with an attention placebo control group. The goal of this study is to decrease HIV incidence in Latino men who have sex with men by engaging their siblings in PrEP-use promotion. In the intervention arm, siblings will be trained to engage their gay brother in PrEP conversations. In the control arm, siblings will be trained to engage their gay brother in conversations about vaccines to prevent COVID, Hepatitis A/B, or MPOX.

Conditions Studied

Interventions

  • BEHAVIORAL Entre Herman@s
  • BEHAVIORAL Vaccines for Health

Study Locations (1)

California

  • Charles R. Drew University of Medicine and Science - Los Angeles

Trial Details

FieldValue
Enrollment Target 288 participants
Start Date 2023-04-29
Est. Completion 2025-06-30
Phase NA

What the Registry Record Tells You About NCT05805306

The ClinicalTrials.gov registry entry for NCT05805306 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 288 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (35% lower). The listed sponsor is Charles Drew University of Medicine and Science, which has 30 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Entre Herman@s is the first listed.

NCT05805306 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05805306 about?

NCT05805306 is a clinical study titled "Entre Herman@s: Promoting Health Among Latino MSM". This is a randomized controlled trial with an attention placebo control group. The goal of this study is to decrease HIV incidence in Latino men who have sex with men by engaging their siblings in PrEP-use promotion. In the intervention arm, siblings will be trained to engage their gay brother in Pr...

What is the current status of trial NCT05805306?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 288 participants. The study started on 2023-04-29. Estimated completion is 2025-06-30.

What conditions does trial NCT05805306 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT05805306?

The interventions under investigation include: Entre Herman@s (BEHAVIORAL), Vaccines for Health (BEHAVIORAL).

Who is sponsoring clinical trial NCT05805306?

This trial is sponsored by Charles Drew University of Medicine and Science, which has 30 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05805306 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.